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Inactivation of the p16/pRB axis is a rate-limiting step
in tumorigenesis. Loss of these tumor suppressors is
well known to disrupt control of cell proliferation but,
additionally, these mutations cause changes in cell meta-
bolism. To investigate the metabolic changes resulting
from pRB inactivation we have exploited a Drosophila
model. Metabolomics and in vivo flux analysis revealed
that RBF-deficient tissues have increased nucleotide pro-
duction and struggle to maintain sufficient pools of
reduced glutathione; ultimately leading to increased sensi-
tivity to oxidative stress. We have now extended these stu-
dies to mammalian cell culture and mice. Depletion of
pRB in non-tumorigenic hTERT-BJ cells leads to an
increased cell population in S-phase and slight increases in
the cell population doubling time. Acute loss of Rb1-/-in
the mouse colon, but not the lung, leads to a robust
increase in Ki67 staining within 96hrs. We therefore asked
to what extent metabolic changes associated with prolif-
eration increases are conserved between pRB-deficient
cells in culture and acute loss of Rb1-/-in vivo.W ep e r -
formed isotopic tracer analyses with both glucose and glu-
tamine and found that while loss of pRB in cell culture
promotes increased isotopic enrichment from U13C-gluta-
mine in TCA cycle intermediates, little to no change was
seen in isotopic enrichment from U13C-glucose. In stark
contrast, acute loss of Rb1 in the mouse colon leads to
robust isotopic enrichment from U13C-glucose in TCA
cycle intermediates and the pyrimidine precursor aspar-
tate; while little to no change in isotopic enrichment from
U13C-glutamine was found in all TCA cycle intermediates
but alpha-ketoglutarate and no significant differences was
seen in aspartate. Collectively these results reveal that loss
of the tumor suppressor pRB has metabolic consequences
in vivo.
Authors’ details
1Massachusetts General Hospital Cancer Center, Harvard Medical School,
Charlestown, MA, USA.
2David H. Koch Institute for Integrative Cancer
Research, MIT, Cambridge, MA, USA.
3Massachusetts Institute of Technology,
Cambridge, MA, USA.
Published: 28 May 2014
doi:10.1186/2049-3002-2-S1-O4
Cite this article as: Nicolay et al.: Metabolic analysis of the loss of Rb1 in
vivo. Cancer & Metabolism 2014 2(Suppl 1):O4.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
1Massachusetts General Hospital Cancer Center, Harvard Medical School,
Charlestown, MA, USA
Full list of author information is available at the end of the article
Nicolay et al. Cancer & Metabolism 2014, 2(Suppl 1):O4
http://www.cancerandmetabolism.com/content/2/S1/O4 Cancer & 
Metabolism
© 2014 Nicolay et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.